Inclusion complex of taxol with 2-hydroxypropyl-beta-cyclodextrin

Details for Australian Patent Application No. 2002347533 (hide)

Owner Vianex S.A.

Inventors Kagkadis, Konstantinos Anastasios

Agent Davies Collison Cave

Pub. Number AU-B-2002347533

PCT Number PCT/IB02/05058

PCT Pub. Number WO2003/043662

Priority 0127677.3 19.11.01 GB

Filing date 15 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 6 September 2007

International Classifications

C07D 305/14 (2006.01) Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 47/40 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cyclodextrins

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 0127677.3 19.11.01 GB

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002347533

6 September 2007 Application Accepted

  Published as AU-B-2002347533

10 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002347534-METHOD FOR PROCESSING A MEMORY LOCATION IN A MEMORY OF A CHIP CARD

2002347532-COMBINATION OF AN ADENOSINE A2A RECEPTOR AGONIST AND AN ADRENERGIC BETA-2 RECEPTOR AGONIST